Prostate Cancer - Results from #2460

Engineering prostate cancer in vitro: what does it take? July 14, 2023

Is Likert better than PI-RADS at predicting prostate cancer on MRI and can a mathematical algorithm achieve similar results? July 14, 2023

Prostate segmentation accuracy using synthetic MRI for high-dose-rate prostate brachytherapy treatment planning. July 13, 2023

A Novel Direction Modulated Brachytherapy Technique for Urethra Sparing in High-Dose-Rate Brachytherapy of Prostate Cancer. July 13, 2023

Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance? July 13, 2023

Mesorectal Nodal Metastasis with Seminal Vesicle Invasion in Biochemically Recurrent Prostate Cancer. July 13, 2023

Impact of Asian Race on Prognosis in De Novo Metastatic Prostate Cancer. July 13, 2023

Prostate Cancer Foundation Partners with Digital Science Press / UroToday to Launch NEW Patient-Centered Website July 12, 2023

The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A review. July 12, 2023

Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer. July 12, 2023

Targeting the Androgen Signaling Axis in Prostate Cancer. July 12, 2023

Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials. July 12, 2023

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). July 12, 2023

Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. July 12, 2023

A Case Report of a Patient With Prostate Adenocarcinoma Metastatic to the Posterior Peritoneum Despite the Negative Preoperative Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Scan. July 11, 2023

The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing July 11, 2023

To boost or not to boost - pooled analyses from two-fraction stereotactic ablative radiotherapy (SABR) trials for localised prostate cancer. July 11, 2023

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial. July 11, 2023

Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy. July 11, 2023

Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound. July 10, 2023

Page 124 of 1439